Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TARS | Common Stock | Options Exercise | +18.9K | +55.25% | 53.1K | Mar 15, 2025 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TARS | Restricted Stock Units | Options Exercise | $0 | -4.46K | -49.99% | $0.00 | 4.46K | Mar 15, 2025 | Common Stock | 4.46K | Direct | F2, F3 | |
transaction | TARS | Restricted Stock Units | Options Exercise | $0 | -7.25K | -33.33% | $0.00 | 14.5K | Mar 15, 2025 | Common Stock | 7.25K | Direct | F2, F4 | |
transaction | TARS | Restricted Stock Units | Options Exercise | $0 | -7.18K | -25% | $0.00 | 21.5K | Mar 15, 2025 | Common Stock | 7.18K | Direct | F2, F5 |
Id | Content |
---|---|
F1 | The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). |
F2 | Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
F3 | RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025 and 2026, subject to the Reporting Person's continuous service. |
F4 | RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service. |
F5 | RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service. |